A director at Rentokil Initial Plc bought 7,500,000 shares at 413p and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week we look at the new record high reached by online shopping during the Cyber Week 2024.
Disclosure of total number of voting rights and number of shares in the capital at October 31, 2024 French limited company (Société anonyme) with registered capital of 106,862,389.20 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at October 31, 2024 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares534,311,946Number of real voting rights (excluding treasury s...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week we look at Deloitte and NRF's predictions for the 2024 holiday shopping season, expec
Two Directors at Vestas Wind Systems AS bought 11,840 shares at between 104.920DKK and 106.000DKK. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND NEWS RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND Clichy, 29 October 2024 – L’Oréal today announces that it has successfully priced a public bond offering for an aggregate nominal amount of €1.25 billion. The offering is composed of two tranches: - A €750 million 3-year fixed rate bond paying a coupon of 2.50 % p.a. - A €500 million 7-year fixed rate bond paying a co...
L’ORÉAL RÉALISE AVEC SUCCÈS UNE ÉMISSION OBLIGATAIRE EN DEUX TRANCHES POUR UN MONTANT TOTAL DE 1,25 MILLIARD D’EUROS COMMUNIQUÉ NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, AU CANADA, AU JAPON OU EN AUSTRALIE L’ORÉAL RÉALISE AVEC SUCCÈS UNE ÉMISSION OBLIGATAIRE EN DEUX TRANCHES POUR UN MONTANT TOTAL DE 1,25 MILLIARD D’EUROS Clichy, le 29 octobre 2024 – L’Oréal a procédé aujourd’hui avec succès au placement d’une émission obligataire d’un montant nominal total de 1,25 milliard d’euros. L’offre est composée de deux tranches :- Une tranche de 750...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week we look at spending patterns in Europe, which show a clear reallocation towards the f
Last week, we organised an Expert Access event on multiple sclerosis (MS) with the participation of Dr Géraldine Androdias, a neurologist at Lyon University Hospital. Dr Androdias presented the key points of the ECTRIMS 2024 conference, as well as new trends in treating the illness. We note an unmet need in the primary progressive and secondary progressive forms, a real interest for the BTKi class with the greater penetration of the blood-brain barrier, and expectations for the anti-C...
Nous avons organisé la semaine dernière un Expert Access autour de la sclérose en plaques (SEP) avec la participation du Dr Géraldine Androdias, médecin neurologue au CHU de Lyon. Le Dr Androdias a présenté les points saillants du congrès de l’ECTRIMS 2024 ainsi que les nouvelles tendances dans la prise en charge de la maladie. Nous retenons un besoin insatisfait dans les formes progressives et secondairement progressives, un vrai intérêt de la classe des BTKi avec le passage accru de...
>Negative reaction expected in trading - Neutral rating maintained, with the target price lowered to € 401. Despite the share’s underperformance since the end of June, a negative reaction is expected following the release of Q3 showing disappointing organic growth of 3.4%. With Q4 seen following a similar trend, organic growth is expected converge towards 5.5% over 2024 (vs VA consensus of 6.9% pre-release). The lowering of organic growth forecasts for 2024 and 2025,...
>Reaction négative attendue - Neutre maintenu avec un OC abaissé à 401 €. Malgré la contre-performance du titre depuis fin juin, une réaction négative est attendue après la publication d’un T3 dont la croissance organique de 3.4% est décevante. Avec un T4 attendu sur une dynamique similaire, l’atterrissage de croissance organique sur 2024 devrait converger vers 5.5% (vs css VA de 6.9% pré-publication). L’abaissement des prévisions de croissance organique sur 2024 et ...
L'Oréal's Q3 sales were below market expectations. After an H1 at +7.3%, sales grew no more than 3.4% organically in Q3 (consensus: +6%) and 6% over 9m. Nevertheless, L'Oréal continued to outperform a dynamic beauty market, albeit less than anticipated at the beginning of the year. (+6%). We remain
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: GLOBAL DOMINION, IBERDROLA, SECTOR ENERGÉTICO. EUROPA: AIR LIQUIDE, L’ORÉAL. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. La deuda enfría los mercados De menos a más, las bolsas europeas terminaron planas en una jornada marcada por las duda...
Sales at 30 September 2024 Solid +6% growth despite turbulences Sales: 32.40 billion euros, +6.0% like-for-like1, +6.0% reported.Growth in all Divisions with L’Oréal Luxe accelerating a third consecutive quarter, Professional Products keeping the rhythm.Growth in all regions,except North Asia, where operating conditions in the Chinese ecosystem remain challenging. Europe continued to deliver a particularly impressive performance.Growth in all categories, with fragrances and haircare most dynamic.Continued growth in both volume and value.Online grew faster than offline...
Chiffre d'affaires au 30 septembre 2024 Solide croissance de + 6 % malgré les turbulences Chiffre d’affaires : 32,40 milliards d’euros, + 6,0 % à données comparables1, + 6,0 % à données publiées.Croissance dans toutes les Divisions: L’Oréal Luxe accélère pour le troisième trimestre consécutif et la Division des Produits Professionnels maintient son rythme.Croissance dans toutes les Zones géographiques, sauf en Asie du Nord, où les conditions de marché de l’écosystème chinois restent difficiles. En Europe, nouvelle performance remarquable.Croissance dans toutes les catégories, portée p...
Disclosure of total number of voting rights and number of shares in the capital at September 30, 2024 French limited company (Société anonyme) with registered capital of 106,991,179.60 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at September 30, 2024 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares534,961,718Number of real voting rights (excluding treasu...
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2024 Société anonyme au capital de 106.991.179,60 euros Siège social : 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisCode LEI (Legal Entité Identifier) : 529900JI1GG6F7RKVI53 Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2024 Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers : Nombre d’actions composant le capital 534 961 718Nombre réel de ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.